医療用加湿器市場 – 2029年までの世界予測

Report Overview

The global Medical humidifier market is projected to reach USD 1,211.7 million by 2029 from USD 922.8 million in 2024, at a CAGR of 5.6% during the forecast period.

世界の医療用加湿器市場は、予測期間中に5.6%のCAGRで成長し、2024年の9億2,280万米ドルから2029年には12億1,170万米ドルに達すると予測されています。

This is due to increasing cases of COPD, asthma, sleep apnea, pneumonia, and bronchitis, growing air pollution, smoking, and climate change are worsening respiratory conditions, necessitating humidification therapy,  newborns and infants, especially premature babies, require humidified oxygen therapy in neonatal intensive care units (NICUs), and aging populations and rising healthcare costs are driving a shift toward home-based treatments. But recurring costs for maintenance, replacement parts (filters, chambers), and energy consumption add to financial burden, and poor maintenance or improper cleaning can lead to bacterial and mold growth, increasing infection risks.

これは、COPD、喘息、睡眠時無呼吸、肺炎、気管支炎の症例が増加していること、大気汚染、喫煙、気候変動の拡大により呼吸器疾患が悪化し加湿療法が必要になっていること、新生児や乳児、特に未熟児は新生児集中治療室（NICU）で加湿酸素療法を必要としていること、人口の高齢化と医療費の上昇により在宅治療への移行が進んでいることが原因です。しかし、メンテナンス、交換部品（フィルター、チャンバー）、エネルギー消費の継続的なコストが経済的負担を増大させ、メンテナンス不足や不適切な清掃は細菌やカビの繁殖につながり、感染リスクを高めます。

“The heated humidifier segment of medical humidifier market by product to hold largest market share during forecast period.”

Based on the product, the medical humidifier market is divided into Heated Humidifier, Bubble Humidifier , Heat and Moisture Exchangers (HMEs), and Humidifier Accessories. Among these, in 2023 heated humidifier segment account for the largest market share of in medical humidifier market. This is due to the increasing use of Heated humidifiers in mechanical ventilation, oxygen therapy, and non-invasive ventilation (NIV) to prevent airway dryness and irritation, rising geriatric population who are more prone to respiratory conditions, and regulatory support from the US Food and Drug Administration (FDA), Conformité Européene (CE) (Europe), and other global bodies ensures product quality and drives market confidence.

“The intensive care unit (ICU) segment of medical humidifier market by application to hold largest market share during the forecast period.”

Based on application, the medical humidifier market is segmented into Intensive Care Unit (ICU), Neonatal Care, Respiratory Therapy, and Other Applications. The intensive care unit (ICU) segment accounts for the largest market share in medical humidifier market due to increasing hospitalizations due to severe respiratory diseases, pneumonia, and post-surgical recovery, premature infants require respiratory support with humidified oxygen in neonatal intensive care units (NICUs), and public and private healthcare investments in ICU capacity expansion are increasing humidifier adoption. Moreover, The pandemic highlighted the need for advanced ICU humidification systems for ventilated patients.

“Asia Pacific to hold the highest CAGR of the medical humidifier market by region.”

The global medical humidifier market is segmented into six major regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. Asia Pacific is estimated to grow at the highest CAGR during the forecast period. This is attributed to an aging population and chronic disease management at home. Japan, South Korea, and China’s aging populations are more likely to develop respiratory problems and require ICU admissions. The governments of China, India, Japan, and Southeast Asia are investing in ICU growth to improve critical care. Low-birth-weight and premature babies often suffer with respiratory problems and need humidified oxygen therapy. The OECD estimates that the average neonatal mortality rate in lower-middle- and low-income APAC countries in 2022 will be 15.6 deaths per 1,000 live births. Japan, China, India, Australia, and the rest of Asia Pacific comprise the region. In the medical humidifier market in 2023 China boasts the highest market share. This is ascribed to China’s aging population, rising awareness, investments in healthcare facilities, and rising frequency of respiratory diseases including COPD and asthma. With more than 280 million individuals aged 60 and above as of the end of 2022, or 19.8% of the whole population, China has the highest aging population worldwide.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1–30%, Tier 2–46%, and Tier 3– 24%
• By Designation: C-level–25%, Director-level–35% and Others–40%
• By Region: North America–40%, Europe–25%, Asia Pacific–19%, Latin America- 8%, Middle east and Africa – 6%, and GCC Countries – 2 %

Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1.0 billion, Tier 2 = USD 500.0 million to USD 1.0 billion, and Tier 3 = <USD 500.0 million.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the medical humidifier market are include ResMed Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Koninklijke Philips N.V. (Netherlands), Vincent Medical Holdings Limited (Hong Kong), Medline Industries, LP. (US), Hamilton Medical (Switzerland), GaleMed Corporation (Taiwan),  and Eakin Healthcare (UK).

Research Coverage

This report studies the medical humidifier market based on product, application, distribution channel, patient type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

• Analysis of Key divers (Rising use of medical humidifiers in ventilation therapy, Increasing prevalence of respiratory diseases, Rising incidence of premature births and advances in neonatal care, Rapid growth in geriatric population), restraints (Frequent replacement of disposable components, increasing operational costs, Low awareness of the threat of respiratory diseases), Challenge (Risk of infectious due to improper maintenance, High cost of advanced humidifiers to limit adoption), opportunity (Post-pandemic demand for respiratory care, Government and non-government initiatives in respiratory health, Increasing investments in hospital infrastructure in emerging markets)

• Market Penetration: Complete knowledge on the spectrum of products presented by the major companies in the medical humidifier market
• Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and new products introductions within the medical humidifier market
• Market Development: Complete knowledge about profitable developing regions
• Market Diversification: Exhaustive knowledge on new goods, expanding geographies, and current changes in the medical humidifier industry helps to diversify the market
• Competitive Assessment: Comprehensive evaluation of market segmentation, development plans, income analysis, and goods of the top market participants.

Table of Contents

1               INTRODUCTION              25

1.1           STUDY OBJECTIVES       25

1.2           MARKET DEFINITION   25

1.3           STUDY SCOPE   26

1.3.1        MARKETS COVERED & REGIONS CONSIDERED  26

1.3.2        INCLUSIONS & EXCLUSIONS       27

1.3.3        YEARS CONSIDERED      27

1.3.4        CURRENCY CONSIDERED            28

1.4           STAKEHOLDERS               28

1.4.1        IMPACT OF AI/GENERATIVE AI 28

2               RESEARCH METHODOLOGY       29

2.1           RESEARCH DATA              29

2.1.1        SECONDARY DATA          30

2.1.1.1    Key data from secondary sources       31

2.1.2        PRIMARY DATA 32

2.1.2.1    Primary sources    32

2.1.2.2    Key data from primary sources           33

2.1.2.3    Key industry insights           34

2.1.2.4    Breakdown of primary interviews      34

2.2           MARKET SIZE ESTIMATION         35

2.2.1        BOTTOM-UP APPROACH              35

2.2.1.1    Approach 1: Company revenue estimation approach     36

2.2.1.2    Approach 2: Presentations of companies and primary interviews                 36

2.2.1.3    Growth forecast    37

2.2.1.4    CAGR projections                 37

2.2.2        TOP-DOWN APPROACH                38

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 39

2.4           MARKET SHARE ASSESSMENT   40

2.5           RESEARCH ASSUMPTIONS           40

2.6           STUDY LIMITATIONS    41

2.7           GROWTH RATE ASSUMPTIONS 41

2.8           RISK ASSESSMENT           41

3               EXECUTIVE SUMMARY  42

4               PREMIUM INSIGHTS       47

4.1           MEDICAL HUMIDIFIER MARKET OVERVIEW        47

4.2           ASIA PACIFIC MEDICAL HUMIDIFIER MARKET SHARE, BY APPLICATION AND COUNTRY             48

4.3           MEDICAL HUMIDIFIER MARKET, BY COUNTRY  49

4.4           MEDICAL HUMIDIFIER MARKET, REGIONAL MIX, 2024 VS. 2029 50

4.5           MEDICAL HUMIDIFIER MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS                50

5               MARKET OVERVIEW       51

5.1           INTRODUCTION              51

5.2           MARKET DYNAMICS       51

5.2.1        DRIVERS               52

5.2.1.1    Rising use of medical humidifiers in ventilation therapy                 52

5.2.1.2    Increasing prevalence of respiratory diseases  53

5.2.1.3    Rising incidence of premature births and advances in neonatal care         54

5.2.1.4    Rapid growth in geriatric population 55

5.2.2        RESTRAINTS      56

5.2.2.1    Frequent replacement of disposable components, increasing operational costs  56

5.2.2.2    Low awareness of threat of respiratory diseases              57

5.2.3        OPPORTUNITIES              57

5.2.3.1    Post-pandemic demand for respiratory care    57

5.2.3.2    Government and non-government initiatives in respiratory health     58

5.2.3.3    Increasing investments in hospital infrastructure in emerging markets  59

5.2.4        CHALLENGES    60

5.2.4.1    Risk of infections due to improper maintenance              60

5.2.4.2    High cost of advanced humidifiers to limit adoption      61

5.3           PRICING ANALYSIS          61

5.3.1        AVERAGE SELLING PRICE TREND, BY KEY PLAYER                 61

5.3.2        AVERAGE SELLING PRICE TREND, BY REGION   62

5.3.3        AVERAGE SELLING PRICE TREND, BY PRODUCT                 63

5.4           VALUE CHAIN ANALYSIS               64

5.4.1        RESEARCH & DEVELOPMENT (R&D)       64

5.4.2        MANUFACTURING          64

5.4.3        DISTRIBUTION AND MARKETING & SALES           64

5.4.4        POST-SALES SERVICES  64

5.5           SUPPLY CHAIN ANALYSIS             65

5.5.1        PROMINENT COMPANIES            65

5.5.2        SMALL AND MEDIUM-SIZED ENTERPRISES          65

5.5.3        END USERS         66

5.6           ECOSYSTEM ANALYSIS  66

5.7           REGULATORY LANDSCAPE         68

5.7.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             68

5.7.2        REGULATORY FRAMEWORK       70

5.7.2.1    North America      70

5.7.2.1.1 US           70

5.7.2.1.2 Canada   71

5.7.2.2    Europe   72

5.7.2.3    Asia Pacific            73

5.7.2.3.1 China      73

5.7.2.3.2 Japan      74

5.7.2.3.3 India       75

5.7.2.4    Latin America       75

5.7.2.4.1 Brazil      75

5.8           PATENT ANALYSIS          75

5.9           TRADE ANALYSIS             77

5.9.1        IMPORT DATA FOR HS CODE 901920       78

5.9.2        EXPORT DATA FOR HS CODE 901920       78

5.10         KEY CONFERENCES & EVENTS, 2025–2026              79

5.11         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       80

5.12         TECHNOLOGY ANALYSIS             81

5.12.1      KEY TECHNOLOGIES     81

5.12.1.1  Heating technology              81

5.12.2      COMPLEMENTARY TECHNOLOGIES       81

5.12.2.1  Bubble diffusion technology                81

5.13         PORTER’S FIVE FORCES ANALYSIS           82

5.13.1      THREAT OF NEW ENTRANTS      83

5.13.2      THREAT OF SUBSTITUTES          84

5.13.3      BARGAINING POWER OF SUPPLIERS       84

5.13.4      BARGAINING POWER OF BUYERS             84

5.13.5      INTENSITY OF COMPETITIVE RIVALRY 84

5.14         KEY STAKEHOLDERS & BUYING CRITERIA            84

5.14.1      KEY STAKEHOLDERS IN BUYING PROCESS           84

5.14.2      BUYING CRITERIA           85

5.15         INVESTMENT & FUNDING SCENARIO     86

5.16         IMPACT OF AI/GENERATIVE AI ON MEDICAL HUMIDIFIER MARKET    87

5.16.1      INTRODUCTION              87

5.16.2      AI USE CASES     88

5.16.3      AI IN MEDICAL HUMIDIFIERS    88

6               MEDICAL HUMIDIFIER MARKET, BY PRODUCT 90

6.1           INTRODUCTION              91

6.2           HEATED HUMIDIFIERS 91

6.2.1        RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET     91

6.3           HEAT & MOISTURE EXCHANGERS            94

6.3.1        RISING DEMAND FOR COST-EFFECTIVE AND DISPOSABLE HMES TO DRIVE MARKET 94

6.4           BUBBLE HUMIDIFIERS  97

6.4.1        TECHNOLOGICAL ADVANCEMENTS IN HUMIDIFICATION SYSTEMS TO PROPEL MARKET GROWTH                 97

6.5           HUMIDIFIER ACCESSORIES         100

6.5.1        INCREASED REPLACEMENT FREQUENCY OF ACCESSORIES TO FUEL DEMAND             100

7               MEDICAL HUMIDIFIER MARKET, BY APPLICATION                 104

7.1           INTRODUCTION              105

7.2           INTENSIVE CARE UNITS                105

7.2.1        INCREASE IN ICU ADMISSIONS TO DRIVE MARKET GROWTH             105

7.3           NEONATAL CARE             108

7.3.1        RISING PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO DRIVE MARKET    108

7.4           RESPIRATORY THERAPY               112

7.4.1        RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE DEMAND   112

7.5           OTHER APPLICATIONS 115

8               MEDICAL HUMIDIFIER MARKET, DISTRIBUTION CHANNEL            118

8.1           INTRODUCTION              119

8.2           HOSPITAL PHARMACIES               119

8.2.1        GROWING PREVALENCE OF RESPIRATORY DISORDERS AND BULK PURCHASES OF MEDICAL HUMIDIFIERS TO DRIVE MARKET               119

8.3           RETAIL PHARMACIES     122

8.3.1        RISING DEMAND FOR HOME-BASED RESPIRATORY CARE SOLUTIONS TO DRIVE MARKET   122

8.4           ONLINE PHARMACIES   124

8.4.1        RISE IN E-COMMERCE ADOPTION AND DIGITAL TRANSFORMATION IN HEALTHCARE TO SUPPORT MARKET GROWTH             124

9               MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE                 128

9.1           INTRODUCTION              129

9.2           ADULT PATIENTS            129

9.2.1        RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE THE MARKET           129

9.3           NEONATAL PATIENTS   133

9.3.1        RISE IN PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO PROPEL MARKET GROWTH             133

9.4           PEDIATRIC PATIENTS   136

9.4.1        RISE IN PRETERM BIRTHS AND NEONATAL COMPLICATIONS TO PROPEL GROWTH                136

10            MEDICAL HUMIDIFIER MARKET, BY END USER 140

10.1         INTRODUCTION              141

10.2         HOSPITALS & AMBULATORY SURGERY CENTERS                 141

10.2.1      RISING NUMBER OF ICU ADMISSIONS AND PREFERENCE FOR AMBULATORY SURGERY TO DRIVE DEMAND                 141

10.3         HOME CARE SETTINGS 144

10.3.1      RISING ELDERLY POPULATION TO DRIVE DEMAND FOR HOME-USE DEVICES      144

10.4         SPECIALTY CLINICS        147

10.4.1      INCREASING PREVALENCE OF CHRONIC RESPIRATORY DISORDERS TO DRIVE MARKET                 147

10.5         OTHER END USERS         150

11            MEDICAL HUMIDIFIER MARKET, BY REGION      154

11.1         INTRODUCTION              155

11.2         NORTH AMERICA             155

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 156

11.2.2      US           160

11.2.2.1  Rising premature births and advances in neonatal care to drive market    160

11.2.3      CANADA               163

11.2.3.1  Increasing prevalence of respiratory diseases to drive market                 163

11.3         EUROPE               167

11.3.1      EUROPE: MACROECONOMIC OUTLOOK               168

11.3.2      GERMANY           171

11.3.2.1  Increasing public healthcare expenditure to foster market growth                 171

11.3.3      UK          174

11.3.3.1  Increasing incidence of respiratory conditions such as COPD and asthma to drive market        174

11.3.4      FRANCE                178

11.3.4.1  High prevalence of COPD to surge demand   178

11.3.5      ITALY    181

11.3.5.1  Increasing geriatric population to support demand for humidifiers            181

11.3.6      SPAIN    184

11.3.6.1  Need to improve healthcare infrastructure due to aging demographic to drive demand            184

11.3.7      REST OF EUROPE             187

11.4         ASIA PACIFIC     190

11.4.1      ASIA PACIFIC: MACROECONOMIC OUTLOOK     191

11.4.2      CHINA  195

11.4.2.1  Growing elderly demographic to propel market              195

11.4.3      JAPAN   198

11.4.3.1  High prevalence of respiratory diseases to drive market growth                 198

11.4.4      INDIA    201

11.4.4.1  Expanding healthcare infrastructure to drive demand   201

11.4.5      AUSTRALIA         205

11.4.5.1  High prevalence of COPD & asthma to drive market growth                 205

11.4.6      REST OF ASIA PACIFIC   208

11.5         LATIN AMERICA                212

11.5.1      HIGH NEONATAL MORTALITY RATE TO DRIVE MARKET                 212

11.5.2      LATIN AMERICA: MACROECONOMIC OUTLOOK                 213

11.6         MIDDLE EAST & AFRICA                216

11.6.1      PRESENCE OF UNSATURATED MARKETS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS     216

11.6.2      MIDDLE EAST &AFRICA: MACROECONOMIC OUTLOOK                 217

11.7         GCC COUNTRIES              220

11.7.1      SIGNIFICANT INVESTMENTS IN DEVELOPMENT AND EXPANSION OF HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET               220

11.7.2      GCC COUNTRIES: MACROECONOMIC OUTLOOK                 222

12            COMPETITIVE LANDSCAPE         225

12.1         OVERVIEW          225

12.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025                 225

12.3         OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS                 226

12.4         REVENUE ANALYSIS, 2021–2023  227

12.5         MARKET SHARE ANALYSIS, 2023                 228

12.5.1      RANKING OF KEY MARKET PLAYERS       229

12.6         COMPANY SHARE ANALYSIS, BY PRODUCT          230

12.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 232

12.7.1      STARS   232

12.7.2      EMERGING LEADERS     232

12.7.3      PERVASIVE PLAYERS      232

12.7.4      PARTICIPANTS 232

12.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         234

12.7.5.1  Company footprint               234

12.7.5.2  Region footprint   235

12.7.5.3  Product footprint  236

12.7.5.4  Application footprint            236

12.7.5.5  End-user footprint                237

12.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        237

12.8.1      PROGRESSIVE COMPANIES         237

12.8.2      RESPONSIVE COMPANIES            237

12.8.3      DYNAMIC COMPANIES  238

12.8.4      STARTING BLOCKS         238

12.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 239

12.8.5.1  Detailed list of key startups/SMEs    239

12.8.5.2  Competitive benchmarking of key emerging players/startups                 239

12.9         COMPANY VALUATION & FINANCIAL METRICS 240

12.9.1      FINANCIAL METRICS      240

12.9.2      COMPANY VALUATION 240

12.10       BRAND/PRODUCT COMPARISON             241

12.11       COMPETITIVE SCENARIO             242

12.11.1   PRODUCT LAUNCHES   242

12.11.2   DEALS  242

12.11.3   EXPANSIONS     243

13            COMPANY PROFILES      244

13.1         KEY PLAYERS     244

13.1.1      FISHER & PAYKEL HEALTHCARE LIMITED            244

13.1.1.1  Business overview 244

13.1.1.2  Products offered   246

13.1.1.3  Recent developments           247

13.1.1.3.1                Product launches  247

13.1.1.3.2                Expansions             247

13.1.1.4  MnM view              247

13.1.1.4.1                Key strengths        247

13.1.1.4.2                Strategic choices made        248

13.1.1.4.3                Weaknesses and competitive threats 248

13.1.2      RESMED INC.     249

13.1.2.1  Business overview 249

13.1.2.2  Products offered   250

13.1.2.3  MnM view              251

13.1.2.3.1                Key strengths        251

13.1.2.3.2                Strategic choices made        251

13.1.2.3.3                Weaknesses and competitive threats 251

13.1.3      DRÄGERWERK AG & CO. KGAA  252

13.1.3.1  Business overview 252

13.1.3.2  Products offered   254

13.1.3.3  MnM view              254

13.1.3.3.1                Key strengths        254

13.1.3.3.2                Strategic choices made        255

13.1.3.3.3                Weaknesses and competitive threats 255

13.1.4      KONINKLIJKE PHILIPS N.V.          256

13.1.4.1  Business overview 256

13.1.4.2  Products offered   258

13.1.5      VINCENT MEDICAL HOLDINGS LIMITED              259

13.1.5.1  Business overview 259

13.1.5.2  Products offered   261

13.1.5.3  Recent developments           261

13.1.5.3.1                Expansions             261

13.1.6      MEDLINE INDUSTRIES, LP.          262

13.1.6.1  Business overview 262

13.1.6.2  Products offered   262

13.1.6.3  Recent developments           263

13.1.6.3.1                Deals      263

13.1.6.3.2                Expansions             265

13.1.7      HAMILTON MEDICAL    266

13.1.7.1  Business overview 266

13.1.7.2  Products offered   266

13.1.7.3  Recent developments           267

13.1.7.3.1                Expansions             267

13.1.8      GALEMED CORPORATION           268

13.1.8.1  Business overview 268

13.1.8.2  Products offered   268

13.1.8.3  Recent developments           269

13.1.8.3.1                Product launches  269

13.1.9      EAKIN HEALTHCARE      270

13.1.9.1  Business overview 270

13.1.9.2  Products offered   270

13.2         OTHER PLAYERS              271

13.2.1      VADI MEDICAL TECHNOLOGY CO., LTD.              271

13.2.2      SHENYANG RMS MEDICAL TECH CO., LTD           272

13.2.3      FLEXICARE (GROUP) LIMITED  273

13.2.4      BESMED HEALTH BUSINESS CORP           274

13.2.5      LÖWENSTEIN MEDICAL SE & CO. KG      275

13.2.6      INTERSURGICAL               276

13.2.7      PRECISION MEDICAL, INC.           277

13.2.8      DRIVE DEVILBISS INTERNATIONAL         277

13.2.9      NEOKRAFT MEDICAL PVT. LTD.                278

13.2.10   DYNAREX CORPORATION            279

13.2.11   HSI LLC.                280

13.2.12   TRUDELL MEDICAL LIMITED     281

13.2.13   GREAT GROUP MEDICAL CO., LTD.         282

13.2.14   FANEM 283

13.2.15   HEYER MEDICAL AG       283

13.2.16   BIOSYS 284

14            APPENDIX           285

14.1         DISCUSSION GUIDE        285

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                290

14.3         CUSTOMIZATION OPTIONS        292

14.4         RELATED REPORTS         292

14.5         AUTHOR DETAILS           293

LIST OF TABLES

TABLE 1                RISK ASSESSMENT: MEDICAL HUMIDIFIER MARKET               41

TABLE 2                US: MORTALITY RATE OF RESPIRATORY DISORDERS        53

TABLE 3                AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER,

2023–2025 (USD)                62

TABLE 4                AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2023–2025 (USD)             63

TABLE 5                AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TYPE, 2023–2025                 63

TABLE 6                MEDICAL HUMIDIFIER MARKET: ROLE OF COMPANIES IN ECOSYSTEM       67

TABLE 7                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  68

TABLE 9                ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  69

TABLE 10              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  69

TABLE 11              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 69

TABLE 12              US FDA: MEDICAL DEVICE CLASSIFICATION                 70

TABLE 13              US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              71

TABLE 14              ISO: INTEGRATION WITH OTHER EQUIPMENT                 72

TABLE 15              CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS      72

TABLE 16              CHINA: CLASSIFICATION OF MEDICAL DEVICES                 73

TABLE 17              JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA   74

TABLE 18              MEDICAL HUMIDIFIER MARKET: INNOVATIONS AND PATENT REGISTRATIONS, JANUARY 2022− FEBRUARY 2025                 77

TABLE 19              IMPORT DATA FOR HS CODE 901920, BY COUNTRY,

2019–2023 (USD THOUSAND)      78

TABLE 20              EXPORT DATA FOR HS CODE 901920, BY COUNTRY,

2019–2023 (USD THOUSAND)      78

TABLE 21              MEDICAL HUMIDIFIER MARKET: KEY CONFERENCES & EVENTS, 2025−2026     79

TABLE 22              MEDICAL HUMIDIFIER MARKET: PORTER’S FIVE FORCES ANALYSIS           82

TABLE 23              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MEDICAL HUMIDIFIERS, BY END USER (%)                 85

TABLE 24              KEY BUYING CRITERIA FOR MEDICAL HUMIDIFIERS, BY END USER       86

TABLE 25              MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION)            91

TABLE 26              KEY HEATED HUMIDIFIERS OFFERED, BY COMPANY           92

TABLE 27              HEATED HUMIDIFIERS MARKET, BY REGION, 2022–2029 (USD MILLION)            92

TABLE 28              HEATED HUMIDIFIER MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)  93

TABLE 29              NORTH AMERICA: HEATED HUMIDIFIERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            93

TABLE 30              EUROPE: HEATED HUMIDIFIERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          93

TABLE 31              ASIA PACIFIC: HEATED HUMIDIFIERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            94

TABLE 32             KEY HEAT & MOISTURE EXCHANGERS OFFERED, BY COMPANY    95

TABLE 33              HEAT & MOISTURE EXCHANGERS MARKET, BY REGION,

2022–2029 (USD MILLION)            95

TABLE 34              NORTH AMERICA: HEAT & MOISTURE EXCHANGERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            96

TABLE 35              EUROPE: HEAT & MOISTURE EXCHANGERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            96

TABLE 36              ASIA PACIFIC: HEAT & MOISTURE EXCHANGERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            97

TABLE 37              KEY BUBBLE HUMIDIFIERS OFFERED, BY COMPANY           98

TABLE 38              BUBBLE HUMIDIFIERS MARKET, BY REGION, 2022–2029 (USD MILLION)            98

TABLE 39              NORTH AMERICA: BUBBLE HUMIDIFIERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            99

TABLE 40              EUROPE: BUBBLE HUMIDIFIERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            99

TABLE 41              ASIA PACIFIC: BUBBLE HUMIDIFIERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            100

TABLE 42              KEY HUMIDIFIER ACCESSORIES OFFERED, BY COMPANY           101

TABLE 43              HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)          101

TABLE 44              NORTH AMERICA: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            102

TABLE 45              EUROPE: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            102

TABLE 46              ASIA PACIFIC: HUMIDIFIER ACCESSORIES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            103

TABLE 47              MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              105

TABLE 48              NUMBER OF ICU BEDS, BY COUNTRY (2024)                 106

TABLE 49              MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS, BY REGION,

2022–2029 (USD MILLION)            106

TABLE 50              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS,

BY COUNTRY, 2022–2029 (USD MILLION)               107

TABLE 51              EUROPE: MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS,

BY COUNTRY, 2022–2029 (USD MILLION)               107

TABLE 52              ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR INTENSIVE CARE UNITS,

BY COUNTRY, 2022–2029 (USD MILLION)               108

TABLE 53              NEONATAL MORTALITY RATES, BY COUNTRY (2022)    109

TABLE 54              MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE, BY REGION,

2022–2029 (USD MILLION)            110

TABLE 55              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE,

BY COUNTRY, 2022–2029 (USD MILLION)               110

TABLE 56              EUROPE: MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE, BY COUNTRY, 2022–2029 (USD MILLION)                 111

TABLE 57              ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR NEONATAL CARE, BY COUNTRY, 2022–2029 (USD MILLION)                 111

TABLE 58              MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY, BY REGION,

2022–2029 (USD MILLION)            113

TABLE 59              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY,

BY COUNTRY, 2022–2029 (USD MILLION)               113

TABLE 60              EUROPE: MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY,

BY COUNTRY, 2022–2029 (USD MILLION)               114

TABLE 61              ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR RESPIRATORY THERAPY,

BY COUNTRY, 2022–2029 (USD MILLION)               114

TABLE 62              MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS, BY REGION,

2022–2029 (USD MILLION)            116

TABLE 63              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               116

TABLE 64              EUROPE: MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            117

TABLE 65              ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               117

TABLE 66              MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            119

TABLE 67              MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES, BY REGION,

2022–2029 (USD MILLION)            120

TABLE 68              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES,

BY COUNTRY, 2022–2029 (USD MILLION)               120

TABLE 69              EUROPE: MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES,

BY COUNTRY, 2022–2029 (USD MILLION)               121

TABLE 70              ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR HOSPITAL PHARMACIES,

BY COUNTRY, 2022–2029 (USD MILLION)               121

TABLE 71              MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES, BY REGION,

2022–2029 (USD MILLION)            123

TABLE 72              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES,

BY COUNTRY, 2022–2029 (USD MILLION)               123

TABLE 73              EUROPE: MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)                 124

TABLE 74              ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR RETAIL PHARMACIES,

BY COUNTRY, 2022–2029 (USD MILLION)               124

TABLE 75              MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES, BY REGION,

2022–2029 (USD MILLION)            125

TABLE 76              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES,

BY COUNTRY, 2022–2029 (USD MILLION)               126

TABLE 77              EUROPE: MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022–2029 (USD MILLION)                 126

TABLE 78              ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR ONLINE PHARMACIES,

BY COUNTRY, 2022–2029 (USD MILLION)               127

TABLE 79              MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)                129

TABLE 80              MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS, BY REGION,

2022–2029 (USD MILLION)            131

TABLE 81              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS,

BY COUNTRY, 2022–2029 (USD MILLION)               131

TABLE 82              EUROPE: MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)                 132

TABLE 83              ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR ADULT PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)                 132

TABLE 84              NUMBER OF NEONATAL DEATHS (2022)                 133

TABLE 85              MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS, BY REGION,

2022–2029 (USD MILLION)            134

TABLE 86              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS,

BY COUNTRY, 2022–2029 (USD MILLION)               135

TABLE 87              EUROPE: MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS,

BY COUNTRY, 2022–2029 (USD MILLION)               135

TABLE 88              ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR NEONATAL PATIENTS,

BY COUNTRY, 2022–2029 (USD MILLION)               136

TABLE 89              MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS, BY REGION,

2022–2029 (USD MILLION)            138

TABLE 90              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS,

BY COUNTRY, 2022–2029 (USD MILLION)               138

TABLE 91              EUROPE: MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY, 2022–2029 (USD MILLION)                 139

TABLE 92              ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR PEDIATRIC PATIENTS,

BY COUNTRY, 2022–2029 (USD MILLION)               139

TABLE 93              MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION)            141

TABLE 94              MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS, BY REGION,

2022–2029 (USD MILLION)            143

TABLE 95              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS,

BY COUNTRY, 2022–2029 (USD MILLION)               143

TABLE 96              EUROPE: MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2022–2029 (USD MILLION)                 144

TABLE 97              ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR HOSPITALS & ASCS,

BY COUNTRY, 2022–2029 (USD MILLION)               144

TABLE 98              MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS, BY REGION,

2022–2029 (USD MILLION)            145

TABLE 99              NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)               146

TABLE 100            EUROPE: MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)               146

TABLE 101            ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2022–2029 (USD MILLION)               147

TABLE 102            MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS, BY REGION,

2022–2029 (USD MILLION)            148

TABLE 103            NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)               149

TABLE 104            EUROPE: MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)               149

TABLE 105            ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR SPECIALTY CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)               150

TABLE 106            MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS, BY REGION,

2022–2029 (USD MILLION)            152

TABLE 107            NORTH AMERICA: MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               152

TABLE 108            EUROPE: MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               153

TABLE 109            ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)               153

TABLE 110            MEDICAL HUMIDIFIER MARKET, BY REGION, 2022–2029 (USD MILLION)            155

TABLE 111            NORTH AMERICA: MACROECONOMIC INDICATORS      156

TABLE 112            NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            157

TABLE 113            NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            158

TABLE 114            NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            158

TABLE 115            NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)            159

TABLE 116            NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            159

TABLE 117            NORTH AMERICA: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            159

TABLE 118            US: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     161

TABLE 119            US: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              162

TABLE 120            US: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            162

TABLE 121            US: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)            162

TABLE 122            US: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION)                163

TABLE 123            CANADA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            165

TABLE 124            CANADA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            165

TABLE 125            CANADA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            166

TABLE 126            CANADA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            166

TABLE 127            CANADA: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            166

TABLE 128            EUROPE: KEY MACROINDICATORS          168

TABLE 129            EUROPE: MEDICAL HUMIDIFIER MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            169

TABLE 130            EUROPE: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)          169

TABLE 131            EUROPE: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            170

TABLE 132            EUROPE: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            170

TABLE 133            EUROPE: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            170

TABLE 134            EUROPE: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            171

TABLE 135            GERMANY: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            172

TABLE 136            GERMANY: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            173

TABLE 137            GERMANY: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            173

TABLE 138            GERMANY: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            173

TABLE 139            GERMANY: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            174

TABLE 140            UK: MORTALITY FROM RESPIRATORY DISEASE, 2018–2023 (ALL AGES)    175

TABLE 141            UK: NUMBER OF PEOPLE RECEIVING DOMICILIARY CARE (HOME CARE) BY NATION 175

TABLE 142            UK: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     176

TABLE 143            UK: MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              176

TABLE 144            UK: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)          177

TABLE 145            UK: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2022–2029 (USD MILLION)            177

TABLE 146            UK: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION)                177

TABLE 147            FRANCE: RESPIRATORY DISEASE PREVALENCE, MORTALITY, AND COST,

BY TYPE (2021)                 178

TABLE 148            FRANCE: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            179

TABLE 149            FRANCE: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            179

TABLE 150            FRANCE: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            180

TABLE 151            FRANCE: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            180

TABLE 152            FRANCE: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            180

TABLE 153            ITALY: RESPIRATORY DISEASE PREVALENCE, MORTALITY, AND COST,

BY TYPE (2021)  181

TABLE 154            ITALY: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     182

TABLE 155            ITALY: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            183

TABLE 156            ITALY: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            183

TABLE 157            ITALY: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            183

TABLE 158            ITALY: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION)                184

TABLE 159            SPAIN: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     185

TABLE 160            SPAIN: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            186

TABLE 161            SPAIN: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            186

TABLE 162            SPAIN: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            186

TABLE 163            SPAIN: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION)                187

TABLE 164            REST OF EUROPE: MORTALITY RATE OF RESPIRATORY DISEASES (2021)  188

TABLE 165            REST OF EUROPE: NEONATE MORTALITY RATE (2022)    188

TABLE 166            REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            189

TABLE 167            REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            189

TABLE 168            REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)            189

TABLE 169            REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            190

TABLE 170            REST OF EUROPE: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            190

TABLE 171            ASIA & PACIFIC: KEY MACROINDICATORS                 191

TABLE 172            ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            193

TABLE 173            ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            193

TABLE 174            ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            194

TABLE 175            ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            194

TABLE 176            ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            194

TABLE 177            ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            195

TABLE 178            CHINA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     196

TABLE 179            CHINA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            196

TABLE 180            CHINA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            197

TABLE 181            CHINA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            197

TABLE 182            CHINA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION)     197

TABLE 183            JAPAN: LEADING CAUSES OF DEATH (2021)                 198

TABLE 184            JAPAN: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     199

TABLE 185            JAPAN: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            200

TABLE 186            JAPAN: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            200

TABLE 187            JAPAN: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            200

TABLE 188            JAPAN: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION)                201

TABLE 189            INDIA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2022–2029 (USD MILLION)     203

TABLE 190            INDIA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            203

TABLE 191            INDIA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            204

TABLE 192            INDIA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            204

TABLE 193            INDIA: MEDICAL HUMIDIFIER MARKET, BY END USER, 2022–2029 (USD MILLION)                204

TABLE 194            AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            207

TABLE 195            AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            207

TABLE 196            AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2022–2029 (USD MILLION)            207

TABLE 197            AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            208

TABLE 198            AUSTRALIA: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            208

TABLE 199            REST OF ASIA PACIFIC: MORTALITY IN CHILDREN UNDER 5 YEARS (2022)            209

TABLE 200            REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            210

TABLE 201            REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          210

TABLE 202            REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)            211

TABLE 203            REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            211

TABLE 204            REST OF ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            211

TABLE 205            LATIN AMERICA: NEONATAL MORTALITY RATE (2022)    212

TABLE 206            LATIN AMERICA & CARIBBEAN: KEY MACROINDICATORS      213

TABLE 207            LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            214

TABLE 208            LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            214

TABLE 209            LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)            215

TABLE 210            LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            215

TABLE 211            LATIN AMERICA: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            215

TABLE 212            MIDDLE EAST & AFRICA: NEONATAL MORTALITY RATE (2022)              217

TABLE 213            MIDDLE EAST & AFRICA: KEY MACROINDICATORS      217

TABLE 214            MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            218

TABLE 215            MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            218

TABLE 216            MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)            219

TABLE 217            MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            219

TABLE 218            MIDDLE EAST & AFRICA: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            219

TABLE 219            GCC COUNTRIES: NEONATAL MORTALITY (2022)    221

TABLE 220            GCC COUNTRIES: KEY MACROINDICATORS                 222

TABLE 221            GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY PRODUCT,

2022–2029 (USD MILLION)            222

TABLE 222            GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            223

TABLE 223            GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL, 2022–2029 (USD MILLION)            223

TABLE 224            GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE,

2022–2029 (USD MILLION)            223

TABLE 225            GCC COUNTRIES: MEDICAL HUMIDIFIER MARKET, BY END USER,

2022–2029 (USD MILLION)            224

TABLE 226            OVERVIEW OF STRATEGIES DEPLOYED BY KEY MEDICAL HUMIDIFIERS MARKET PLAYERS, JANUARY 2022–FEBRUARY 2025 226

TABLE 227            MEDICAL HUMIDIFIER MARKET: DEGREE OF COMPETITION 228

TABLE 228            MEDICAL HUMIDIFIER MARKET: REGION FOOTPRINT       235

TABLE 229            MEDICAL HUMIDIFIER MARKET: PRODUCT FOOTPRINT       236

TABLE 230            MEDICAL HUMIDIFIER MARKET: APPLICATION FOOTPRINT       236

TABLE 231            MEDICAL HUMIDIFIER MARKET: END-USER FOOTPRINT       237

TABLE 232            MEDICAL HUMIDIFIER MARKET: DETAILED LIST OF KEY STARTUPS/SMES   239

TABLE 233            MEDICAL HUMIDIFIER MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS                 239

TABLE 234            MEDICAL HUMIDIFIER MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–FEBRUARY 2025                 242

TABLE 235            MEDICAL HUMIDIFIER MARKET: DEALS, JANUARY 2022–FEBRUARY 2025  242

TABLE 236            MEDICAL HUMIDIFIER MARKET: EXPANSIONS, JANUARY 2022–FEBRUARY 2025  243

TABLE 237            FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW   244

TABLE 238            FISHER & PAYKEL HEALTHCARE LIMITED: CURRENCY CONVERSION            245

TABLE 239            FISHER & PAYKEL HEALTHCARE LIMITED.: PRODUCTS OFFERED    246

TABLE 240            FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES,

JANUARY 2022–JANUARY 2025     247

TABLE 241            FISHER & PAYKEL HEALTHCARE LIMITED: EXPANSIONS,

JANUARY 2022–JANUARY 2025     247

TABLE 242            RESMED INC.: COMPANY OVERVIEW      249

TABLE 243            RESMED INC.: PRODUCTS OFFERED       250

TABLE 244            DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW          252

TABLE 245            DRÄGERWERK AG & CO. KGAA: CURRENCY CONVERSION    253

TABLE 246            DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED             254

TABLE 247            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          256

TABLE 248            KONINKLIJKE PHILIPS N.V.: CURRENCY CONVERSION (EURO TO USD)  257

TABLE 249            KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED             258

TABLE 250            VINCENT MEDICAL HOLDINGS LIMITED: COMPANY OVERVIEW   259

TABLE 251            VINCENT MEDICAL HOLDINGS LIMITED: CURRENCY CONVERSION (EURO TO USD)           260

TABLE 252            VINCENT MEDICAL HOLDINGS LIMITED: PRODUCTS OFFERED    261

TABLE 253            VINCENT MEDICAL HOLDINGS LIMITED: EXPANSIONS,

JANUARY 2022–JANUARY 2025     261

TABLE 254            MEDLINE INDUSTRIES, LP.: COMPANY OVERVIEW          262

TABLE 255            MEDLINE INDUSTRIES, LP.: PRODUCTS OFFERED             262

TABLE 256            MEDLINE INDUSTRIES, LP.: DEALS, JANUARY 2022–JANUARY 2025         263

TABLE 257            MEDLINE INDUSTRIES, LP.: EXPANSIONS, JANUARY 2022–JANUARY 2025     265

TABLE 258            HAMILTON MEDICAL: COMPANY OVERVIEW                 266

TABLE 259            HAMILTON MEDICAL: PRODUCTS OFFERED                 266

TABLE 260            HAMILTON MEDICAL: EXPANSIONS, JANUARY 2022–JANUARY 2025         267

TABLE 261            GALEMED CORPORATION: COMPANY OVERVIEW          268

TABLE 262            GALEMED CORPORATION: PRODUCTS OFFERED             268

TABLE 263            GALEMED CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JANUARY 2025             269

TABLE 264            EAKIN HEALTHCARE: COMPANY OVERVIEW                 270

TABLE 265            EAKIN HEALTHCARE: PRODUCTS OFFERED                 270

LIST OF FIGURES

FIGURE 1              MEDICAL HUMIDIFIER MARKET: RESEARCH DESIGN                29

FIGURE 2              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND

DEMAND-SIDE PARTICIPANTS  34

FIGURE 3              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     35

FIGURE 4              BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH              36

FIGURE 5              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 37

FIGURE 6              TOP-DOWN APPROACH                38

FIGURE 7              DATA TRIANGULATION                39

FIGURE 8              MEDICAL HUMIDIFIER MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)      42

FIGURE 9              MEDICAL HUMIDIFIER MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)       43

FIGURE 10            MEDICAL HUMIDIFIER MARKET, BY DISTRIBUTION CHANNEL,

2024 VS. 2029 (USD MILLION)      43

FIGURE 11            MEDICAL HUMIDIFIER MARKET, BY PATIENT TYPE, 2024 VS. 2029 (USD MILLION)         44

FIGURE 12            MEDICAL HUMIDIFIER MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)      45

FIGURE 13            GEOGRAPHICAL SNAPSHOT OF MEDICAL HUMIDIFIER MARKET    46

FIGURE 14            INCREASING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE THE MARKET           47

FIGURE 15            INTENSIVE CARE UNITS ACCOUNTED FOR LARGEST SHARE IN 2023                48

FIGURE 16            CHINA TO RECORD HIGHEST GROWTH RATE FROM 2024 TO 2029          49

FIGURE 17            ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD       50

FIGURE 18            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING

FORECAST PERIOD         50

FIGURE 19            MEDICAL HUMIDIFIER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          51

FIGURE 20            MEDICAL HUMIDIFIER MARKET: VALUE CHAIN ANALYSIS            65

FIGURE 21            MEDICAL HUMIDIFIER MARKET: SUPPLY CHAIN ANALYSIS            66

FIGURE 22            MEDICAL HUMIDIFIER MARKET: ECOSYSTEM ANALYSIS            67

FIGURE 23            MEDICAL HUMIDIFIER MARKET: PATENT ANALYSIS,

JANUARY 2015–DECEMBER 2024 76

FIGURE 24            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           80

FIGURE 25            MEDICAL HUMIDIFIER MARKET: PORTER’S FIVE FORCES ANALYSIS           83

FIGURE 26            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF MEDICAL HUMIDIFIERS, BY END USER        85

FIGURE 27            KEY BUYING CRITERIA FOR MEDICAL HUMIDIFIERS, BY END USER       86

FIGURE 28            MEDICAL HUMIDIFIER MARKET: INVESTMENT & FUNDING SCENARIO 2022−2024            87

FIGURE 29            US: NUMBER OF RESPIRATORY THERAPISTS                 112

FIGURE 30            US: TRENDS IN COPD, BY AGE   130

FIGURE 31            US: PRETERM BIRTH RATE, 2018–2023     134

FIGURE 32            UK AND IRELAND: ADMISSIONS TO PEDIATRIC INTENSIVE CARE UNITS,

2020–2022              137

FIGURE 33            NORTH AMERICA: MEDICAL HUMIDIFIER MARKET SNAPSHOT       157

FIGURE 34            US: INFANT MORTALITY RATE (2021 & 2022)                 160

FIGURE 35            CANADA: DEATHS RELATED TO RESPIRATORY DISORDERS (2019–2023) 164

FIGURE 36            GERMANY: TRENDS IN UNDER-FIVE MORTALITY RATE           172

FIGURE 37            SPAIN: TRENDS IN UNDER-FIVE MORTALITY RATE (2018–2023)              184

FIGURE 38            ASIA PACIFIC: MEDICAL HUMIDIFIER MARKET SNAPSHOT          192

FIGURE 39            JAPAN: MORTALITY RATE IN UNDER-FIVE AGE GROUP 199

FIGURE 40            INDIA: INCIDENCE OF TRACHEA, BRONCHUS, AND LUNG CANCER, BY AGE GROUP (2022 & 2045)            202

FIGURE 41            AUSTRALIA: PREVALENCE OF COPD, BY AGE GROUP (2001–2022)          205

FIGURE 42            AUSTRALIA: TRENDS OVER TIME FOR COPD HOSPITALIZATIONS AMONG PEOPLE AGED 45+ YEARS (2015–16 TO 2021–22)         206

FIGURE 43            GCC COUNTRIES: AGE DEMOGRAPHICS, BY COUNTRY (2023)               220

FIGURE 44            MEDICAL HUMIDIFIER MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD BILLION)    227

FIGURE 45            MEDICAL HUMIDIFIER MARKET SHARE ANALYSIS, 2023  228

FIGURE 46            RANKING OF KEY PLAYERS IN MEDICAL HUMIDIFIER MARKET, 2023         229

FIGURE 47            HEATED HUMIDIFIERS MARKET SHARE, BY KEY PLAYER (2023)   230

FIGURE 48            HEAT & MOISTURE EXCHANGERS MARKET SHARE, BY KEY PLAYER (2023)    231

FIGURE 49            BUBBLE HUMIDIFIERS MARKET SHARE, BY KEY PLAYER (2023)   231

FIGURE 50            MEDICAL HUMIDIFIER MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023       233

FIGURE 51            MEDICAL HUMIDIFIER MARKET: COMPANY FOOTPRINT       234

FIGURE 52            MEDICAL HUMIDIFIER MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 238

FIGURE 53            EV/EBITDA OF KEY VENDORS   240

FIGURE 54            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS            240

FIGURE 55            MEDICAL HUMIDIFIER MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     241

FIGURE 56            FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2024)      245

FIGURE 57            RESMED INC.: COMPANY SNAPSHOT (2024)                 250

FIGURE 58            DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)             253

FIGURE 59            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)             257

FIGURE 60            VINCENT MEDICAL HOLDINGS LIMITED: COMPANY SNAPSHOT (2023)      260

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 栄養補助食品用包装市場 – 2030年までの世界予測 2025-04-07
• 産業用ボイラー市場 – 2030年までの世界予測 2025-04-04
• オープンギア用潤滑油市場 – 2030年までの世界予測 2025-04-04
• 建設重機市場 – 2030年までの世界予測 2025-04-03
• 従来の創傷ケア市場 – 2030年までの世界予測 2025-04-02

MarketsandMarkets  出版レポート一覧